October Pharma S.A.E (EGX:OCPH)
Egypt · Delayed Price · Currency is EGP 390.74
-4.99 (-1.26%)
At close: May 14, 2026
October Pharma S.A.E Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 185.66 | 151.84 | 182.13 | 130.75 | 119.79 | 88.26 |
Depreciation & Amortization | 40.57 | 30.12 | 22.51 | 22 | 20.8 | 18.82 |
Loss (Gain) From Sale of Assets | -0.07 | -4.1 | -0.24 | -0.34 | - | -0.05 |
Provision & Write-off of Bad Debts | 16.97 | 7.78 | 5.76 | 0.94 | 2.21 | - |
Other Operating Activities | 135.81 | 123.98 | 102.07 | 42.76 | 55.6 | 40.1 |
Change in Accounts Receivable | 234.8 | -26.82 | -70.98 | -49.56 | -12.86 | -11.11 |
Change in Inventory | -80.36 | -154.32 | 84.44 | -89.2 | -26.75 | -52.84 |
Change in Accounts Payable | -37.59 | 68.24 | -10.28 | 50.46 | -4.59 | -2.45 |
Change in Other Net Operating Assets | -124.57 | -153.5 | -162.12 | -200.13 | 107.93 | -27.44 |
Operating Cash Flow | 371.22 | 43.24 | 153.29 | -92.33 | 262.13 | 53.3 |
Operating Cash Flow Growth | 1434.27% | -71.79% | - | - | 391.81% | -44.52% |
Capital Expenditures | -15.55 | -53.06 | -35.31 | -92.67 | -19.7 | -5.65 |
Sale of Property, Plant & Equipment | 1 | 4.11 | 0.25 | 0.36 | - | 0.05 |
Sale (Purchase) of Intangibles | - | - | -0.35 | -1.99 | -1.7 | -1.38 |
Investing Cash Flow | -14.55 | -48.94 | -35.4 | -94.31 | -21.4 | -6.98 |
Short-Term Debt Issued | - | 210.52 | 13.69 | 188.26 | - | - |
Long-Term Debt Issued | - | - | - | 60.92 | - | - |
Total Debt Issued | -21.15 | 210.52 | 13.69 | 249.19 | - | - |
Short-Term Debt Repaid | - | - | - | - | -136.65 | -2.4 |
Long-Term Debt Repaid | - | -11.24 | -12.47 | - | -24.83 | -12.02 |
Total Debt Repaid | -109.68 | -11.24 | -12.47 | - | -161.48 | -14.42 |
Net Debt Issued (Repaid) | -130.83 | 199.28 | 1.22 | 249.19 | -161.48 | -14.42 |
Common Dividends Paid | -20.54 | -55.48 | -17.95 | -44.66 | -34.19 | -14.86 |
Other Financing Activities | -181.75 | -130.86 | -62.77 | -27.7 | -30.2 | -31.91 |
Financing Cash Flow | -333.11 | 12.94 | -79.51 | 176.83 | -225.87 | -61.18 |
Net Cash Flow | 19.97 | 7.23 | 38.38 | -9.81 | 14.86 | -14.86 |
Free Cash Flow | 355.67 | -9.82 | 117.98 | -185 | 242.43 | 47.65 |
Free Cash Flow Growth | - | - | - | - | 408.80% | -24.17% |
Free Cash Flow Margin | 24.33% | -0.80% | 11.66% | -25.43% | 37.01% | 8.77% |
Free Cash Flow Per Share | 29.64 | -0.82 | 9.83 | -15.42 | 20.20 | 3.97 |
Cash Interest Paid | 140.51 | 130.86 | 62.77 | - | 30.2 | 31.91 |
Cash Income Tax Paid | 57.43 | 61.55 | 41.29 | 37.37 | 22.7 | 10.53 |
Levered Free Cash Flow | 248.07 | -86.83 | 25.35 | -239 | 200.33 | -9.99 |
Unlevered Free Cash Flow | 335.89 | -5.05 | 64.58 | -221.68 | 219.2 | 9.95 |
Change in Working Capital | -7.72 | -266.39 | -158.94 | -288.43 | 63.73 | -93.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.